Skip to content

Insider · CIK 0001759142

Brian Grow

officer

Files at ORGO (Organogenesis Holdings Inc.). First filing -, latest -.

In brief

Brian Grow files SEC Form 4 as officer at ORGO (Organogenesis Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Brian Grow has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 21 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 10, 2025ORGO
Organogenesis Holdings Inc.
MOption exercise
Class A Common Stock
+958$1.24$1,188900,682Apr 24, 2026
Jan 10, 2025ORGO
Organogenesis Holdings Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-958$0.00$00Apr 24, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+48,818$0.00$0911,611Mar 3, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-11,887$3.84$46k899,724Mar 3, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+234,375$0.00$0862,793Feb 20, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+48,330$0.00$0911,123Feb 20, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-11,768$3.84$45k899,355Feb 20, 2026
Feb 18, 2026ORGO
Organogenesis Holdings Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+133,630$0.00$0133,630Feb 20, 2026
Feb 15, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-3,346$3.73$12k669,031Feb 18, 2026
Feb 15, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-18,910$3.73$71k650,121Feb 18, 2026
Feb 15, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-10,559$3.73$39k639,562Feb 18, 2026
Feb 15, 2026ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-11,144$3.73$42k628,418Feb 18, 2026
Aug 11, 2025ORGO
Organogenesis Holdings Inc.
MOption exercise
Class A Common Stock
+4,060$2.47$10k674,550Aug 13, 2025
Aug 11, 2025ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-2,173$4.62$10k672,377Aug 13, 2025
Aug 11, 2025ORGO
Organogenesis Holdings Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-4,060$0.00$00Aug 13, 2025
Feb 19, 2025ORGO
Organogenesis Holdings Inc.
AGrant or award
Class A Common Stock
+183,067$0.00$0670,490Feb 21, 2025
Feb 19, 2025ORGO
Organogenesis Holdings Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+189,369$0.00$0189,369Feb 21, 2025
Feb 15, 2025ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-10,559$3.70$39k510,250Feb 19, 2025
Feb 15, 2025ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-19,423$3.70$72k490,827Feb 19, 2025
Feb 15, 2025ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-2,748$3.70$10k488,079Feb 19, 2025
Feb 16, 2025ORGO
Organogenesis Holdings Inc.
FTax withholding
Class A Common Stock
-656$3.70$2,427487,423Feb 19, 2025

Questions about Brian Grow

Answered from the filings on this page, as of the latest one.

Is Brian Grow buying or selling?

Brian Grow has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Brian Grow's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Grow has 0.

Where does Brian Grow file Form 4?

Brian Grow has filed Form 4 at ORGO (Organogenesis Holdings Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brian Grow: insider trades and track record | InsiderTell